BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12388556)

  • 1. Gangliosides activate Trk receptors by inducing the release of neurotrophins.
    Rabin SJ; Bachis A; Mocchetti I
    J Biol Chem; 2002 Dec; 277(51):49466-72. PubMed ID: 12388556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine regulation of nerve growth factor expression by Trk receptors.
    Mallei A; Rabin SJ; Mocchetti I
    J Neurochem; 2004 Sep; 90(5):1085-93. PubMed ID: 15312164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain.
    Duchemin AM; Ren Q; Mo L; Neff NH; Hadjiconstantinou M
    J Neurochem; 2002 May; 81(4):696-707. PubMed ID: 12065629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gangliosides prevent excitotoxicity through activation of TrkB receptor.
    Bachis A; Rabin SJ; Del Fiacco M; Mocchetti I
    Neurotox Res; 2002 May; 4(3):225-34. PubMed ID: 12829403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of neurotrophin-3 to p75LNGFR, TrkA, and TrkB mediated by a single functional epitope distinct from that recognized by trkC.
    Rydén M; Ibáñez CF
    J Biol Chem; 1996 Mar; 271(10):5623-7. PubMed ID: 8621424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid stimulatory effects of brain-derived neurotrophic factor and neurotrophin-3 on somatostatin release and intracellular calcium rise in primary hypothalamic cell cultures.
    Marmigère F; Choby C; Rage F; Richard S; Tapia-Arancibia L
    Neuroendocrinology; 2001 Jul; 74(1):43-54. PubMed ID: 11435757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K-252b potentiation of neurotrophin-3 is trkA specific in cells lacking p75NTR.
    Maroney AC; Sanders C; Neff NT; Dionne CA
    J Neurochem; 1997 Jan; 68(1):88-94. PubMed ID: 8978713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p75 reduces TrkB tyrosine autophosphorylation in response to brain-derived neurotrophic factor and neurotrophin 4/5.
    Vesa J; Kruttgen A; Shooter EM
    J Biol Chem; 2000 Aug; 275(32):24414-20. PubMed ID: 10825163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Neuroprotection by an Engineered Neurotrophin that Selectively Activates Tropomyosin Receptor Kinase (Trk) Family Neurotrophin Receptors but Not the p75 Neurotrophin Receptor.
    Brahimi F; Galan A; Siegel S; Szobota S; Sarunic MV; Foster AC; Saragovi HU
    Mol Pharmacol; 2021 Nov; 100(5):491-501. PubMed ID: 34470776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
    Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
    Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive phosphorylation of TrkC receptors in cultured cerebellar granule neurons might be responsible for the inability of NT-3 to increase neuronal survival and to activate p21 Ras.
    Zirrgiebel U; Lindholm D
    Neurochem Res; 1996 Jul; 21(7):851-9. PubMed ID: 8873090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides in the differentiation process of primary neurons: the specific role of GM1-oligosaccharide.
    Di Biase E; Lunghi G; Fazzari M; Maggioni M; Pomè DY; Valsecchi M; Samarani M; Fato P; Ciampa MG; Prioni S; Mauri L; Sonnino S; Chiricozzi E
    Glycoconj J; 2020 Jun; 37(3):329-343. PubMed ID: 32198666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p75 Co-receptors regulate ligand-dependent and ligand-independent Trk receptor activation, in part by altering Trk docking subdomains.
    Zaccaro MC; Ivanisevic L; Perez P; Meakin SO; Saragovi HU
    J Biol Chem; 2001 Aug; 276(33):31023-9. PubMed ID: 11425862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tyrosine kinase receptors in cultured dorsal root ganglion neurons in the presence of monosialoganglioside and skeletal muscle cells.
    Li H; Zhang W; Liu G; Li J; Liu H; Li Z
    J Muscle Res Cell Motil; 2012 Oct; 33(5):341-50. PubMed ID: 22968393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas.
    Perez-Pinera P; Hernandez T; García-Suárez O; de Carlos F; Germana A; Del Valle M; Astudillo A; Vega JA
    Mol Cell Biochem; 2007 Jan; 295(1-2):19-26. PubMed ID: 16862449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of phosphorylation of TrkB and TrkC and their signal transduction by alpha2-macroglobulin.
    Hu YQ; Koo PH
    J Neurochem; 1998 Jul; 71(1):213-20. PubMed ID: 9648868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of endogenous GM1 ganglioside on TrkB activity, in cultured neurons.
    Pitto M; Mutoh T; Kuriyama M; Ferraretto A; Palestini P; Masserini M
    FEBS Lett; 1998 Nov; 439(1-2):93-6. PubMed ID: 9849885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Trk neurotrophin receptors in the absence of neurotrophins.
    Lee FS; Chao MV
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3555-60. PubMed ID: 11248116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GM1 binds to the Trk protein and regulates receptor function.
    Mutoh T; Tokuda A; Miyadai T; Hamaguchi M; Fujiki N
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5087-91. PubMed ID: 7539142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trk receptors need neutral sphingomyelinase activity to promote cell viability.
    Candalija A; Cubí R; Ortega A; Aguilera J; Gil C
    FEBS Lett; 2014 Jan; 588(1):167-74. PubMed ID: 24316227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.